|LETTER TO EDITOR
|Year : 2019 | Volume
| Issue : 1 | Page : 67
Serological screening of hepatitis B virus and hepatitis C virus among patients attending a tertiary hospital in Jalingo, Taraba state, Nigeria
Mahmood Dhahir Al-Mendalawi
Department of Paediatrics, Al-Kindy College of Medicine, University of Baghdad, Baghdad, Iraq
|Date of Web Publication||16-May-2019|
Prof. Mahmood Dhahir Al-Mendalawi
P.O. Box 55302, Baghdad Post Office, Baghdad
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Al-Mendalawi MD. Serological screening of hepatitis B virus and hepatitis C virus among patients attending a tertiary hospital in Jalingo, Taraba state, Nigeria. Saudi J Health Sci 2019;8:67
|How to cite this URL:|
Al-Mendalawi MD. Serological screening of hepatitis B virus and hepatitis C virus among patients attending a tertiary hospital in Jalingo, Taraba state, Nigeria. Saudi J Health Sci [serial online] 2019 [cited 2021 Jul 24];8:67. Available from: https://www.saudijhealthsci.org/text.asp?2019/8/1/67/258124
I read with interest the study by Omote et al. published in the September–December 2018 issue of the Saudi Journal for Health Sciences. The authors studied the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among patients seen in a tertiary health facility in Jalingo, Taraba state, Nigeria. They found that 13.6%, 16.6%, and 1% were positive of HBV, HCV, and coinfection, respectively. I presume that the following methodological limitation might cast some suspicions on the accuracy of the study results. It is explicit that there are bidirectional relationships between human immunodeficiency virus (HIV) and several sexually transmitted infections, including HBV and HCV. On the one hand, HIV might affect the clinical picture, treatment outcome, and progression of HBV and HCV. On the other hand, the presence of HBV and HCV infections might increase both genital and plasma HIV ribonucleic acid (RNA) levels and thus, augment the transmission of HIV infection. Nigeria is one of the Sub-Saharan countries substantially affected with HIV epidemic. The recently published data pointed out to 12.9% HIV seroprevalence in Nigeria with urban/rural disparity. The coinfections of HIV, HBV, and HCV are worrisome health issue in Nigeria where the seroprevalences of HBV/HCV, HIV/HBV, HIV/HCV, and HIV/HBV/HCV coinfection were 1.3%, 1.3%, 1.5%, and 0.4%, respectively. Defining HIV status in the studied cohort in Omote et al.'s study by the diagnostic algorithm of viral overload and CD4 lymphocyte count estimations would have envisaged. Hence, HIV positivity ought to be considered an important exclusion criterion in the study methodology.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Omote V, Kashibu E, Ojumah I, Adda D, Etaghene J, Ukwamedua H. Serological screening of hepatitis B virus and hepatitis C virus among patients attending a tertiary hospital in Jalingo, Taraba state, Nigeria. Saudi J Health Sci 2018;7:167-71. [Full text]
Chun HM, Carpenter RJ, Macalino GE, Crum-Cianflone NF. The role of sexually transmitted infections in HIV-1 progression: A comprehensive review of the literature. J Sex Transm Dis 2013;2013:176459.
Okonkwo UC, Okpara H, Otu A, Ameh S, Ogarekpe Y, Osim H, et al.
Prevalence of hepatitis B, hepatitis C and human immunodeficiency viruses, and evaluation of risk factors for transmission: Report of a population screening in Nigeria. S Afr Med J 2017;107:346-51.